Related Experiment Videos
Ticagrelor versus Clopidogrel in Peripheral Artery Disease
Manesh R Patel1, F Gerry R Fowkes2, William R Hiatt3
1Duke University School of Medicine, Durham, NC manesh.patel@duke.edu.
The New England Journal of Medicine
|April 14, 2017
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Understanding Study Drug Discontinuation Through EUCLID.
Frontiers in cardiovascular medicine·2022
Total Cardiovascular and Limb Events and the Impact of Polyvascular Disease in Chronic Symptomatic Peripheral Artery Disease.
Journal of the American Heart Association·2022
Etiology and outcomes of amputation in patients with peripheral artery disease in the EUCLID trial.
Journal of vascular surgery·2021
World regional differences in outcomes for patients with peripheral artery disease: Insights from the EUCLID trial.
Vascular medicine (London, England)·2021
Association of Heart Failure With Outcomes Among Patients With Peripheral Artery Disease: Insights From EUCLID.
Journal of the American Heart Association·2021
Syncope.
The New England journal of medicine·2026
Extensive Biventricular Subendocardial Infarction with Cardiogenic Shock as Secondary Brain Hit in an Asphyxiated Neonate-Case Report.
Fetal and pediatric pathology·2026
A Rare Case of Hemobilia due to Hepatic Artery Pseudoaneurysm (HAPA) in the right Hepatic Artery-Segment 8 branch and its Management via Coil Embolization.
Nigerian medical journal : journal of the Nigeria Medical Association·2026
Chronic brucellosis presenting as cardiac implantable electronic device-related endocarditis: diagnostic challenges and management-a case report.
European heart journal. Case reports·2026